GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Other Current Liabilities

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Other Current Liabilities : ¥6.9 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Other Current Liabilities?

Zhejiang Shengda Bio-Pharm Co's other current liabilities for the quarter that ended in Mar. 2024 was ¥6.9 Mil.

Zhejiang Shengda Bio-Pharm Co's quarterly other current liabilities declined from Sep. 2023 (¥4.0 Mil) to Dec. 2023 (¥3.2 Mil) but then increased from Dec. 2023 (¥3.2 Mil) to Mar. 2024 (¥6.9 Mil).

Zhejiang Shengda Bio-Pharm Co's annual other current liabilities increased from Dec. 2021 (¥6.9 Mil) to Dec. 2022 (¥10.0 Mil) but then declined from Dec. 2022 (¥10.0 Mil) to Dec. 2023 (¥3.2 Mil).


Zhejiang Shengda Bio-Pharm Co Other Current Liabilities Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Other Current Liabilities Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zhejiang Shengda Bio-Pharm Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Zhejiang Shengda Bio-Pharm Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Headlines

No Headlines